<?xml version="1.0" encoding="UTF-8"?>
<p>Asian traditional herbal medicine based on Traditional Chinese Medicine (TCM) has been widely used for the treatment of kidney disease in China, Korea, and Japan for a long time. Although several herbs containing constituents such as aristolochic acids and other plant alkaloids have been found to cause side effects, including nephrotoxicity [
 <xref rid="B14" ref-type="bibr">14</xref>], increasing evidences show that some polyherbal formulas, single herbs, and their main components have significant efficacy in AKI models via anti-inflammatory, antioxidant, or antiapoptotic activities [
 <xref rid="B3" ref-type="bibr">3</xref>, 
 <xref rid="B15" ref-type="bibr">15</xref>]. Notably, Xuebijing consisting of 
 <italic>Radix Paeoniae Rubra</italic>, 
 <italic>Chuan dome</italic>, 
 <italic>Salvia miltiorrhiza</italic>, safflower, and Chinese angelica improves renal function in patients with scald injury-induced AKI [
 <xref rid="B16" ref-type="bibr">16</xref>]. Traditional polyherbal formulas are designed to control the balance of body functions, and the formula containing various medicinal herbs has been developed for greater synergistic and fewer side effects based on information in clinical records accumulated over time. Systems pharmacology has recently emerged as a useful tool for understanding the nature of traditional medicine formulas and their mechanisms [
 <xref rid="B17" ref-type="bibr">17</xref>, 
 <xref rid="B18" ref-type="bibr">18</xref>].
</p>
